Niven Mehra
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations
Schmid S, De Giorgi U, Hansen A, Beer T, Lavaud P, Morales-Barrera R, Tucci M, Castro E, Karalis K, Bergman A, Le M, Zürrer-Härdi U, Pezaro C, Suzuki H, Zivi A, Klingbiel D, Schär S, Bianchini D, Chi K, Omlin A, Higano C, Sweeney C, Martinez Chanza N, Mehra N, Kuppen M, Beltran H, Conteduca V, Vargas Pivato de Almeida D, Cotait Maluf F, Oh W, Tsao C, Sartor O, Ledet E, Di Lorenzo G, Yip S, Gillessen S. Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations. JAMA Netw Open 2020; 3:e2021692.
Oct 1, 2020Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations
Oct 1, 2020JAMA Netw Open 2020; 3:e2021692
Schmid Sabine, De Giorgi Ugo, Hansen Aaron R, Beer Tomasz M, Lavaud Pernelle, Morales-Barrera Rafael, Tucci Marcello, Castro Elena, Karalis Kostas, Bergman Andries M, Le Mo Linh, Zürrer-Härdi Ursina, Pezaro Carmel, Suzuki Hiroyoshi, Zivi Andrea, Klingbiel Dirk, Schär Sämi, Bianchini Diletta, Chi Kim N, Omlin Aurelius, Higano Celestia, Sweeney Christopher, Martinez Chanza Nieves, Mehra Niven, Kuppen Malou C P, Beltran Himisha, Conteduca Vincenza, Vargas Pivato de Almeida Daniel, Cotait Maluf Fernando, Oh William K, Tsao Che-Kai, Sartor Oliver, Ledet Elisa, Di Lorenzo Giuseppe, Yip Steven M, Gillessen Silke
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Rescigno P, Romero-Laorden N, Castro E, Saez M, Mehra N, Smeenk S, Sideris S, Gil T, Banks P, Sandhu S, Sternberg C, De Giorgi U, Olmos D, Morley C, Pezaro C, Dolling D, Conteduca V, Rediti M, Bianchini D, Lolli C, Ong M, Li H, Omlin A, Schmid S, Caffo O, Zivi A, de Bono J. Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis. Eur Urol Oncol 2019
Jul 12, 2019Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Jul 12, 2019Eur Urol Oncol 2019
Rescigno Pasquale, Romero-Laorden Nuria, Castro Elena, Saez Maria I, Mehra Niven, Smeenk Stella, Sideris Spyridon, Gil Thyerry, Banks Patricia, Sandhu Shaneen K, Sternberg Cora N, De Giorgi Ugo, Olmos David, Morley Courtney, Pezaro Carmel J, Dolling David, Conteduca Vincenza, Rediti Mattia, Bianchini Diletta, Lolli Cristian, Ong Michael, Li Haoran, Omlin Aurelius, Schmid Sabine, Caffo Orazio, Zivi Andrea, de Bono Johann S
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
Sumanasuriya S, Luo J, Mehra N, Olmos D, Scher H, Soule H, Stoecklein N, Terstappen L, Waugh D, Lorente D, Lolkema M, Omlin A, Armstrong A, Attard G, Chi K, Bevan C, Shibakawa A, IJzerman M, De Laere B, de Bono J. Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer. Eur Urol Oncol 2018; 1:151-159.
May 15, 2018Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
May 15, 2018Eur Urol Oncol 2018; 1:151-159
Sumanasuriya Semini, Luo Jun, Mehra Niven, Olmos David, Scher Howard, Soule Howard, Stoecklein Nikolas H, Terstappen Leon W M M, Waugh David, Lorente David, Lolkema Martijn, Omlin Aurelius, Armstrong Andrew, Attard Gerhardt, Chi Kim N, Bevan Charlotte L, Shibakawa Aki, IJzerman Maarten J, De Laere Bram, de Bono Johann S
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey
Lorente D, Hall E, IJzerman M, Terstappen L, Payne H, Mateo J, Perez R, Tunariu N, Bianchini D, Porta N, Kolinsky M, Rescigno P, Miranda M, Gilman A, Omlin A, Pezaro C, Mehra N, Ravi P, de Bono J. Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey. Eur Urol Focus 2016; 4:235-244.
Oct 10, 2016Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey
Oct 10, 2016Eur Urol Focus 2016; 4:235-244
Lorente David, Hall Emma, IJzerman Maarten, Terstappen Leon, Payne Heather, Mateo Joaquin, Perez Raquel, Tunariu Nina, Bianchini Diletta, Porta Nuria, Kolinsky Michael, Rescigno Pasquale, Miranda Miguel, Gilman Alexa, Omlin Aurelius, Pezaro Carmel, Mehra Niven, Ravi Praful, de Bono Johann
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
Lorente D, Crespo M, Flohr P, Mateo J, Altavilla A, Ferraldeschi R, Bianchini D, Attard G, Tunariu N, Miranda S, Riisnaes R, Omlin A, Zafeiriou Z, Nava-Rodrigues D, Pérez-López R, Pezaro C, Mehra N, Sheridan E, Figueiredo I, de Bono J. Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses. Clin Genitourin Cancer 2016; 14:485-493.
May 5, 2016Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
May 5, 2016Clin Genitourin Cancer 2016; 14:485-493
Lorente David, Crespo Mateus, Flohr Penny, Mateo Joaquin, Altavilla Amelia, Ferraldeschi Roberta, Bianchini Diletta, Attard Gerhardt, Tunariu Nina, Miranda Susana, Riisnaes Ruth, Omlin Aurelius, Zafeiriou Zafeiris, Nava-Rodrigues Daniel, Pérez-López Raquel, Pezaro Carmel, Mehra Niven, Sheridan Elizabeth, Figueiredo Ines, de Bono Johann